ArticleScientific reports2025

The cost effectiveness of penpulimab with paclitaxel and carboplatin in first-line treatment of metastatic squamous non-small cell lung cancer.

Kaiqi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.